Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Por um escritor misterioso
Descrição
SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic
Full article: A novel class of broad-spectrum active-site-directed
Frontiers Potency, Safety, and Pharmacokinetic Profiles of
Unveiling the molecular mechanism of SARS-CoV-2 main protease
RCSB PDB - 7L14: CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV
Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main
Frontiers Recent Progress in the Drug Development Targeting SARS
Frontiers Structural Basis of Potential Inhibitors Targeting
IJMS, Free Full-Text
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease
Future Pharmacology, Free Full-Text
Covalent and non-covalent binding free energy calculations for
Potential SARS-CoV-2 main protease inhibitors - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)